Our CEO, Immanuel Lerner will be visiting Singapore, and attending the J-Labs Singapore Family Office Investor Event.
In addition to attending the J-Labs Singapore Family Office Investor Event, he will be in Singapore from September 14-17 for additional meetings with collaborators in the peptide therapeutics space.
Pepticom joins Johnson & Johnson’s global incubator network JLABS EMEA & Singapore, as a virtual member company
Pepticom Ltd. is proud to be a virtual member company of Johnson & Johnson‘s global incubator network, JLABS, in EMEA and Singapore. JLABS is the largest global network of open innovation ecosystems, enabling and empowering emerging companies with the knowledge, experience, partnerships, and venture connections across a broad healthcare spectrum including pharmaceutical and medical technology […]
Our CEO Immanuel Lerner will be presenting at the DDIF 15th Annual Drug Discovery Innovation Forum in Berlin on September 5th
Our CEO Immanuel Lerner has been selected to speak at the #DDIF 15th Annual Drug Discovery Innovation Forum in Berlin, on September 4-5, 2024!
Our COO Maayan Elias Robicsek will attend Biomed Israel 2025, May 21-23/2024
Our COO Maayan Elias Robicsek is attending Biomed Israel 2025! Come and say hello to learn about our AI drug discovery platform
Dr. Sarah Benson-Konforty joining the Board of Directors and Executive Committee of the AAIH
Pepticom is excited to be taking an active role in shaping the future of AI in healthcare — Congratulations to Dr. Sarah Benson-Konforty, MD for joining the Board of Directors and Executive Committee of the The Alliance for Artificial Intelligence in Healthcare (AAIH)
Pepticom joined The Alliance for Artificial Intelligence in Healthcare (AAIH)
The AAIH is a coalition of technology developers, pharmaceutical companies, and research organizations who share our goal of leveraging #AI to advance the quality of healthcare, with a special focus on AI-guided pharmaceutical development.Our advisor, Sarah Benson-Konforty, will attend our first AAIH Annual Members Meeting this May 17-18th in San Francisco.
Our CEO and co-founder, Dr. Immanuel Lerner will be speaking at TIDES Asia 2023
Dr. Immanuel Lerner, CEO and co-founder of Pepticom, will speak at the TIDES Asia conference between March 7-9. His lecture will be about The Potential and Current Application of Artificial Intelligence in Peptide Drug Discovery. The conference will take place in Kyoto, from March 7-9, and he will be available for meetings there as well […]
JP Morgan Healthcare Conference, San Francisco, January 9-10, 2023
The Pepticom Ltd. team, Our CEO Immanuel Lerner and Sarah Benson-Konforty, MD are attending the conference. You can meet them at our booth at the Health Innovation Lounge, the on-site hub of the Israeli health, tech & innovation community, and is located at 447 Sutter Street – a 2 min walk from the Westin St. Francis Hotel.